Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$466M |
| 2 |
Applovin
APP
|
+$349M |
| 3 |
General Dynamics
GD
|
+$272M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$257M |
| 5 |
iShares Global Infrastructure ETF
IGF
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$396M |
| 2 |
HES
Hess
HES
|
+$383M |
| 3 |
Apple
AAPL
|
+$362M |
| 4 |
NVIDIA
NVDA
|
+$298M |
| 5 |
Microsoft
MSFT
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.46% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Communication Services | 8.8% |
| 5 | Healthcare | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Anixa Biosciences
ANIX
$116M
| $188K | ﹤0.01% |
56,960
-9,722
| -15% | -$30.8K |
|
4002
Research Solutions
RSSS
$73.6M
| $187K | ﹤0.01% |
50,095
| – | – |
|
4003
Immix Biopharma
IMMX
$592M
| $187K | ﹤0.01% |
89,301
-4,587
| -5% | -$11K |
|
4004
QuickLogic
QUIK
$232M
| $187K | ﹤0.01% |
30,781
+791
| +3% | +$4.67K |
|
4005
Immunic
IMUX
$190M
| $186K | ﹤0.01% |
21,135
-4,697
| -18% | -$41.4K |
|
4006
Canadian Solar
CSIQ
$1.02B
| $186K | ﹤0.01% |
14,281
-10,518
| -42% | -$126K |
|
4007
Caesarstone
CSTE
$72.3M
| $186K | ﹤0.01% |
117,110
-40,977
| -26% | -$66.8K |
|
4008
Coya Therapeutics
COYA
$98.3M
| $184K | ﹤0.01% |
32,321
-7,055
| -18% | -$42.9K |
|
4009
CervoMed
CRVO
$23.9M
| $182K | ﹤0.01% |
22,554
-2,800
| -11% | -$24K |
|
4010
Plus Therapeutics
PSTV
$26.6M
| $182K | ﹤0.01% |
+10,620
| New | +$130K |
|
|
FIRY
4011
Firy Inc
FIRY
$148M
| $180K | ﹤0.01% |
22,504
-4,891
| -18% | -$37.6K |
|
4012
TriplePoint Venture Growth BDC
TPVG
$184M
| $180K | ﹤0.01% |
31,155
+2,123
| +7% | +$14.1K |
|
4013
TScan Therapeutics
TCRX
$48.6M
| $179K | ﹤0.01% |
98,548
| – | – |
|
|
MRDN
4014
Meridian Holdings Inc
MRDN
$143M
| $179K | ﹤0.01% |
13,217
+1,105
| +9% | +$18.1K |
|
|
BTM
4015
DELISTED
Bitcoin Depot
BTM
| $178K | ﹤0.01% |
7,560
+3,337
| +79% | +$105K |
|
4016
American Well
AMWL
$180M
| $178K | ﹤0.01% |
28,873
-27
| -0.1% | -$199 |
|
4017
First Guaranty Bancshares
FGBI
$159M
| $177K | ﹤0.01% |
22,040
-3,601
| -14% | -$30.1K |
|
4018
Lifetime Brands
LCUT
$191M
| $177K | ﹤0.01% |
45,645
-10,785
| -19% | -$45.9K |
|
4019
Intellicheck
IDN
$73.1M
| $176K | ﹤0.01% |
33,925
| – | – |
|
4020
flyExclusive
FLYX
$60.1M
| $176K | ﹤0.01% |
+35,605
| New | +$122K |
|
4021
Where Food Comes From
WFCF
$61.1M
| $175K | ﹤0.01% |
13,175
-951
| -7% | -$11.2K |
|
4022
ALX Oncology
ALXO
$261M
| $174K | ﹤0.01% |
95,160
-40,749
| -30% | -$35.3K |
|
|
LGCY
4023
Legacy Education Inc
LGCY
$149M
| $174K | ﹤0.01% |
+18,169
| New | +$212K |
|
4024
MediciNova
MNOV
$65.5M
| $171K | ﹤0.01% |
134,743
-4,995
| -4% | -$6.46K |
|
4025
VistaGen Therapeutics
VTGN
$9.89M
| $171K | ﹤0.01% |
48,093
| – | – |
|
Similar funds
Northern Trust's Q3 2025 Portfolio in Review
As of Q3 2025, Northern Trust held 4,566 positions worth $782B, up 7.5% from $727B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Northern Trust's Q3 2025 filing shows 167 new, 1,770 increased, 2,268 reduced and 144 closed positions. Its largest new stake was Amrize Ltd: 1,020,799 shares worth $49.5M. The largest sale was Ansys, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Northern Trust's largest Q3 2025 buy was Amrize Ltd: 1,020,799 shares worth $49.5M.
- Northern Trust added most to Chevron in Q3 2025, an estimated $466M increase.
- Northern Trust's biggest Q3 2025 reduction was Apple, cutting an estimated $362M.
- Northern Trust fully exited Ansys in Q3 2025, selling an estimated $396M.
- Northern Trust's ten largest holdings make up 30% of its $782B portfolio in Q3 2025.
- Northern Trust opened 167 new positions and closed 144 in Q3 2025.
- Northern Trust's portfolio value rose 7.5% quarter-over-quarter to $782B.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.